Argyle

Overview

Argyle is a notable high-CBD indica-dominant strain that gained considerable recognition after being commercialized by Canadian cannabis producer Tweed, now a subsidiary of Canopy Growth Corporation. Named after the classic diamond-patterned textile design, Argyle was bred specifically to meet the demands of medical cannabis patients requiring high concentrations of cannabidiol with minimal tetrahydrocannabinol. The strain traces its lineage to Warwick and Nordle genetics, two foundational high-CBD cultivars developed through meticulous selective breeding programs. Argyle's cannabinoid profile consistently delivers CBD concentrations ranging from 12 to 20 percent, making it one of the more potent CBD-dominant strains available in the regulated Canadian medical market. The plant expresses characteristic indica morphology with broad, dark green leaves, compact internodal spacing, and dense, chunky bud structure. Its flowers are coated in a generous layer of crystalline trichomes that reflect the high cannabinoid content within. The terpene composition of Argyle features prominent myrcene levels alongside notable caryophyllene and humulene presence, contributing to its distinctly earthy, musky aroma profile with underlying notes of hops and spice. Patients utilizing Argyle frequently report significant relief from chronic pain conditions, multiple sclerosis symptoms, arthritis, and generalized anxiety disorder. The near-absence of THC ensures that therapeutic benefits can be accessed without cognitive impairment, making Argyle suitable for daytime medical use. Cultivators appreciate Argyle for its robust plant structure, moderate growing requirements, and relatively predictable yield outcomes. The strain performs exceptionally well in controlled indoor environments where temperature and humidity can be carefully regulated to optimize resin production. Outdoor cultivation is feasible in temperate climates with growing seasons long enough to accommodate the 60 to 65 day flowering period. Argyle represents a benchmark in pharmaceutical-grade cannabis cultivation, demonstrating that indica genetics can be harnessed effectively to produce therapeutic CBD-rich medicine.

Effects

Terpenes

Genetics